leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 00:16:47 - browse：739

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

WSS

Merck drug for rare lung condition set for approval in U.S.

White House announces new plan to address the growing threat of xylazine in overdose crisis

White House announces new plan to address the growing threat of xylazine in overdose crisis

Pandemic and All Hazards Preparedness Act needs lean update

ACA's risk program benefits Blue Cross Blue Shield insurers

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

explore

leisure time

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Biden targets hefty hospital 'facility fees' that often surprise patients

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Merck, Vertex, and Viking updates

Psychedelics group wrestles with new pharma identity

Why the world’s most expensive drug might be worth the price

Virginia high school admissions case could be legal follow

FDA's naming rule on biosimilars has undermined competition

Activists slam private health insurers over coverage restrictions

Supreme Court mifepristone arguments center on docs' right to sue

hotspot

Biden’s NIH nominee is languishing in Congress

Teachers share how revamped forgiveness program helped with their student loans

Abortion pill Supreme Court ruling could impact entire drug industry

Pandemic and All Hazards Preparedness Act needs lean update

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Abortion pill case raises question: who can sue the FDA?

focus

leisure time

leisure time

explore